CLINICAL_TRIALS
trial_result
· 2008-08-21
Clinical Trial Update: Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [Phase 3]
Summary
A completed Phase 3 study evaluating Xaliproden (SR57746A) in patients with mild-to-moderate Alzheimer's-type dementia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED